Sanofi-Aventis (NYSE:SNY): Current price $47.41
On Monday, Sanofi announced that regulators had okayed its Lyxumia, an injectable diabetes treatment, for sale in Europe. The drug is also known by its generic name, lixisenatide, and is taken once a day along with other drugs or insulin by patients who are otherwise unable to control their blood sugar levels. Lyxumia represents one of the new products the firm is banking on to bring growth back after losing several star performers to generic competition.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.